TPO antibody positivity and adverse pregnancy outcomes.
levothyroxine
miscarriage
preterm birth
thyroid autoimmunity
thyroid peroxidase antibodies
Journal
Best practice & research. Clinical endocrinology & metabolism
ISSN: 1878-1594
Titre abrégé: Best Pract Res Clin Endocrinol Metab
Pays: Netherlands
ID NLM: 101120682
Informations de publication
Date de publication:
07 2020
07 2020
Historique:
pubmed:
5
9
2020
medline:
15
12
2020
entrez:
5
9
2020
Statut:
ppublish
Résumé
Thyroid autoimmunity (TAI) is prevalent amongst women of reproductive age. TAI describes the presence of circulating anti-thyroid autoantibodies that are targeted against the thyroid, with or without thyroid dysfunction. Thyroid peroxidase antibodies (TPOAb) are the most common anti-thyroid autoantibodies. Around 10% of biochemically euthyroid individuals also have an elevated TPOAb titre. Many studies have linked the presence of TPOAb to adverse maternal and fetal outcomes in pregnancy, in particular miscarriage and pre-term birth, even in the absence of thyroid dysfunction. The causal pathway is poorly understood and few trials have looked to find treatments to reduce adverse outcomes. This review discusses in detail the associated adverse outcomes of TPOAb in pregnancy and the results of trials exploring methods to reduce such outcomes. Recommendations for counselling and monitoring of women with TPOAb and suggested areas for future work are also outlined.
Identifiants
pubmed: 32883611
pii: S1521-690X(20)30060-9
doi: 10.1016/j.beem.2020.101433
pii:
doi:
Substances chimiques
Autoantibodies
0
thyroid microsomal antibodies
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
101433Subventions
Organisme : Medical Research Council
ID : MC_G1002674
Pays : United Kingdom
Informations de copyright
Crown Copyright © 2020. Published by Elsevier Ltd. All rights reserved.